Upload Avatar (500 x 500)
Han Shujun
shujunhan456351@xjtu.edu.cn
Chinese, English
Shaanxi
Xi'an Jiaotong University
Life Sciences
  • 2009-2013 Bachelor: Northwest A&F University, College of Animal Science and Technology
  • 2013-2019 PhD: Xi'an Jiaotong University, School of Life Sciences and Technology
  • 2017-2018 Joint PhD Training: University of California, Davis, School of Medicine
  • 2019-present: Associate Professor, Xi'an Jiaotong University, School of Life Sciences and Technology
  • Xi'an Jiaotong University 'Top Ten Academic Newcomers'
  • Xi'an Jiaotong University Young Outstanding Talent
Tumor signal transduction
Targeted therapy
Molecular mechanisms of drug resistance
  • lncRNA SAMMSON mediates adaptive resistance to RAF inhibition in BRAF-mutant melanoma cells, Han Shujun et al., 2021
  • CPT1A/2-mediated mitochondrial FAO in breast cancer stem cells as a potential target for breast cancer radiotherapy, Han Shujun et al., 2019
  • ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma, Han Shujun et al., 2018
  • SIRT3/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress, Han Shujun et al., 2018
  • O-GlcNAcase deficiency suppresses skeletal myogenesis and insulin sensitivity in mice through the modulation of mitochondrial homeostasis, Han Shujun et al., 2016
  • High-Fat-Diet-Induced Weight Gain Ameliorates Bone Loss without Exacerbating AβPP Processing and Cognition in Female APP/PS1 Mice, Han Shujun et al., 2014
  • 抑癌基因MIG-6与肿瘤, 韩戍君等, 2014
Cancer Signaling Therapy Resistance Molecular Mechanisms Targeted Drug Transduction Tumor

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.